Oncolytics (ONCY) Biotech announced the appointment of Andrew Aromando as Chief Business Officer. Aromando most recently served as COO at Ambrx Biopharma.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.